about
The human RNA surveillance factor UPF1 is required for S phase progression and genome stabilityA quantitative telomeric chromatin isolation protocol identifies different telomeric statesHuman protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitroThe human CST complex is a terminator of telomerase activityTERRA: telomeric repeat-containing RNAA practical qPCR approach to detect TERRA, the elusive telomeric repeat-containing RNAThe THO complex component Thp2 counteracts telomeric R-loops and telomere shorteningSaccharomyces cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated mRNA decay.Intracellular trafficking of yeast telomerase components.Tel1 kinase and subtelomere-bound Tbf1 mediate preferential elongation of short telomeres by telomerase in yeast.A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressedA three-state model for the regulation of telomerase by TERRA and hnRNPA1Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome endsProtein RNA and protein protein interactions mediate association of human EST1A/SMG6 with telomeraseTERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeresThe shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7Yeast telomerase is specialized for C/A-rich RNA templates.Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activityTelomerase and chromosome end maintenance.Molecular basis for telomere repeat divergence in budding yeastThe non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomeraseTelomerase limits the extent of base pairing between template RNA and telomeric DNA.Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways.Functional characterization of the TERRA transcriptome at damaged telomeres.Telomerase: biochemical considerations for enzyme and substrate.Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast.Fingering the ends: how to make new telomeres.Telomerase repeat addition processivity is increased at critically short telomeres in a Tel1-dependent manner in Saccharomyces cerevisiaeReevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of actionTelomere length homeostasis.Telomere length homeostasis responds to changes in intracellular dNTP pools.CST for the grand finale of telomere replication.Molecular basis of telomere syndrome caused by CTC1 mutations.Telomerase is essential to alleviate pif1-induced replication stress at telomeres.TERRA biogenesis, turnover and implications for function.Telomere functions grounding on TERRA firma.Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.An affinity oligonucleotide displacement strategy to purify ribonucleoprotein complexes applied to human telomerase.3'-end labeling of RNA with recombinant yeast poly(A) polymerase.Peroxiredoxin 1 Protects Telomeres from Oxidative Damage and Preserves Telomeric DNA for Extension by Telomerase.
P50
Q24305135-1C25F839-1531-42E6-BAAF-BBB62809522FQ24309504-BCDF1E66-807A-41C3-899D-7E52689BBCF3Q24337394-F90A9950-EA93-44AE-B9C0-71C90B14FE97Q24339504-D9255037-8A70-4543-9CB8-A60F3B9DBD00Q24656014-2A8F3717-D3A6-4A85-B90E-CF656654F8D7Q26741150-A9A157A8-82F1-4DDF-B4DC-C9D1E9CFE0E9Q27929516-016D85E0-AE25-4098-A199-BE601E18592FQ27930308-072E2688-9FBE-458A-A8E0-08EF43DA4C9EQ27930619-973616B5-631E-4314-A5BF-14A87196A48CQ27936234-FE111CA6-5CF6-44ED-8934-42D57BD8C367Q28116014-80A34B76-B2E1-4E58-969A-F3334CC9FB10Q28116200-37F6F5FA-38E3-4FCA-BA13-69D14F41B21FQ28116571-F351AEC7-CBAC-4C49-882A-7273C87D45FAQ28117179-356C2316-40CA-49E7-A9C0-57B17A9ADAA2Q28118158-92701554-0229-4B55-898B-0CE703BDAA74Q28118567-DC6F4972-B68C-4517-A30D-342119299F67Q30310619-3DCBCBF1-651A-4BAB-80B7-5C8735288E26Q30471100-5A2AE8A6-925E-43B2-9700-0FD04C8486DCQ30472155-972FCAA7-5E78-4262-A183-7A7306082FDEQ34012621-799E135F-5CEB-417C-BBB5-8B655CA6210CQ34146428-9AE522A4-AA0C-40E1-B6C9-72055A731535Q34166762-7BB0B133-EFEB-429E-B2FF-22591E156850Q34178088-51323ECA-ECD4-4696-B8E3-ED089C2A2EACQ34687678-A24261FA-54B9-4442-9A59-8D0FEA336399Q34989394-77F8FCAC-7497-4665-8DB7-34FBC942FB0BQ35082669-9B589233-6DBA-4467-89D2-6879A2E00F8BQ35145486-D739F474-5C5C-4885-99D6-EAF7E4A88827Q36012625-86AC2142-333C-4484-B170-8A97AAD42019Q36141416-1E3C05EF-9310-4DD3-95BE-D565BB650749Q36495238-3AC5E436-5371-417D-B98D-12673C40DF2AQ36709911-350FF14D-9809-4537-81D1-445E996A6E3DQ37260942-5BF140C4-0619-4B40-BBE5-D8B72786558CQ37362550-5FE199CC-EFCC-45D4-8FA2-24BF183180D4Q37425005-619E940D-2A8E-469C-BE64-C15499C75239Q37775273-B200585D-3AFC-4929-84A4-61F59E772B51Q38254471-487C2063-3588-440C-B819-91217DB61483Q38291849-015F2C99-7237-4449-9A58-489D496DDA75Q38359373-005FA609-55B4-4AF4-AF2F-8BE9A16FF390Q40407905-7BAF43E6-F1D3-4775-99A7-2FD96B2F577BQ46441183-CA095F24-93C6-4A4D-9FB2-5E8D1167719D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joachim Lingner
@ast
Joachim Lingner
@en
Joachim Lingner
@es
Joachim Lingner
@nl
Joachim Lingner
@sl
type
label
Joachim Lingner
@ast
Joachim Lingner
@en
Joachim Lingner
@es
Joachim Lingner
@nl
Joachim Lingner
@sl
prefLabel
Joachim Lingner
@ast
Joachim Lingner
@en
Joachim Lingner
@es
Joachim Lingner
@nl
Joachim Lingner
@sl
P214
P106
P1153
7004509264
P214
P31
P496
0000-0002-2853-5803
P735
P7859
lccn-n2008181820